4//SEC Filing
Atlas Venture Associates X, LLC 4
Accession 0001209191-21-051015
CIK 0001815442other
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 10:42 AM ET
Size
8.6 KB
Accession
0001209191-21-051015
Insider Transaction Report
Form 4
ATLAS VENTURE ASSOCIATES X, L.P.
10% Owner
Transactions
- Sale
Common Stock
2021-08-11$61.00/sh−242,133$14,770,113→ 0 total
Holdings
- 5,763,012(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]The shares reported herein give effect to the pro rata distribution of shares by Atlas Venture Fund X, L.P. ("Atlas Venture Fund X"), on May 18, 2021, for no additional consideration to its limited partners and its general partner, Atlas Venture Associates X, L.P. ("AVA X LP"), subsequent to the Reporting Persons' last Section 16 filing reporting ownership of the Issuer's Common Stock. As the distribution of such shares constituted only a change in the form of the Reporting Persons' ownership in such shares, the Reporting Persons were not required to report the distribution pursuant to Section 16.
- [F2]The shares are held directly by AVA X LP. Atlas Venture Associates X, LLC ("AVA X LLC") is the general partner of AVA X LP. AVA X LLC disclaims Section 16 beneficial ownership of the securities held by AVA X LP except to the extent of its pecuniary interest therein, if any.
- [F3]These shares are held directly by Atlas Venture Fund X. The general partner of Atlas Venture Fund X is AVA X LP and the general partner of AVA X LP is AVA X LLC. Each of AVA X LP and AVA LLC disclaims Section 16 beneficial ownership of the securities held by Atlas Venture Fund X, except to the extend of its respective pecuniary interest therein, if any.
Documents
Issuer
Kymera Therapeutics, Inc.
CIK 0001815442
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001742765
Filing Metadata
- Form type
- 4
- Filed
- Aug 11, 8:00 PM ET
- Accepted
- Aug 12, 10:42 AM ET
- Size
- 8.6 KB